EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies

por Tremblay-LeMay, Rosemarie, Rastgoo, Nasrin, Pourabdollah, Maryam, Chang, Hong
Publicado en Biomark Res (2018)

High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide

por Pourabdollah, Maryam, Bahmanyar, Mohammad, Atenafu, Eshetu G., Reece, Donna, Hou, Jian, Chang, Hong
Publicado en J Hematol Oncol (2016)

Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma

por Rastgoo, Nasrin, Wu, Jian, Liu, Aijun, Pourabdollah, Maryam, Atenafu, Eshetu G., Reece, Donna, Chen, Wenming, Chang, Hong
Publicado en Haematologica (2019)